AQST vs DUK · rev $28.3M vs P/E 19, rev $31.74B
Aquestive Therapeutics Inc (AQST) versus Duke Energy Corporation (DUK) — a side-by-side from cached financials, not a winner call.
Aquestive Therapeutics Inc (AQST) is a drug manufacturers - specialty & generic company listed on US.
Duke Energy Corporation (DUK) is a utilities - regulated electric company listed on NYSE.
Latest reported AQST revenue for 2026-06-30 was $28.3M. Net income was -$30.9M. Revenue was up 95.7% from 2026-03-31 to 2026-06-30. AQST currently screens at market cap $493.0M.
Latest reported DUK revenue for 2025-12-31 was $31.74B. Net income was $4.97B. Revenue was up 5.6% from 2024-12-31 to 2025-12-31. DUK currently screens at market cap $96.46B and trailing P/E 19.0.
AQST currently screens at market cap $493.0M. DUK currently screens at market cap $96.46B and trailing P/E 19.0.
Not investment advice. Open the AQST and DUK stock pages for the full models.
Not investment advice.